Skip to main content
. 2014 Dec 4;308(3):R208–R218. doi: 10.1152/ajpregu.00409.2014

Fig. 3.

Fig. 3.

Mean change in measures of arterial stiffness (A) and endothelium independent vasodilatation (EID) (B) after 12 wk of treatment with placebo vs. 6R-BH4. There was a significantly greater reduction in central augmentation index (AIx), AIx corrected for heart rate (AIx at 75), and a significant improvement in EID in the 6R-BH4 group compared with placebo. There was no difference in change in pulse wave velocity (PWV) between the groups. *P < 0.05.